Antal Zemplenyi
Antal Zemplenyi
University of Pecs and University of Colorado
Verified email at
Cited by
Cited by
The effect of performance-volume limit on the DRG based acute care hospital financing in Hungary
D Endrei, A Zemplényi, B Molics, I Ágoston, I Boncz
Health Policy 115 (2-3), 152-156, 2014
Cost‐effectiveness analysis of intensity‐modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer
AT Zemplényi, Z Kaló, G Kovacs, R Farkas, T Beöthe, D Bányai, ...
European Journal of Cancer Care 27 (1), e12430, 2018
Direct healthcare cost of schizophrenia–European overview
G Kovács, T Almási, A Millier, M Toumi, M Horváth, K Kóczián, Á Götze, ...
European Psychiatry 48 (1), 79-92, 2018
Surrogate endpoints in health technology assessment: an international review of methodological guidelines
B Grigore, O Ciani, F Dams, C Federici, S de Groot, M Möllenkamp, ...
Pharmacoeconomics 38 (10), 1055-1070, 2020
The patient at the centre: evidence from 17 European integrated care programmes for persons with complex needs
T Czypionka, M Kraus, M Reiss, E Baltaxe, J Roca, S Ruths, J Stokes, ...
BMC health services research 20, 1-14, 2020
Defining good health and care from the perspective of persons with multimorbidity: results from a qualitative study of focus groups in eight European countries
FRM Leijten, M Hoedemakers, V Struckmann, M Kraus, S Cheraghi-Sohi, ...
BMJ open 8 (8), e021072, 2018
Cost-effectiveness analysis of invasive EEG monitoring in drug-resistant epilepsy
S Kovács, M Tóth, J Janszky, T Dóczi, D Fabó, I Boncz, L Botz, ...
Epilepsy & Behavior 114, 107488, 2021
Implementation of palliative care consult Service in Hungary–integration barriers and facilitators
AT Zemplényi, Á Csikós, M Csanádi, MR Mölken, C Hernandez, JG Pitter, ...
BMC palliative care 19, 1-12, 2020
ápilis 1-i egészségügyi reform intézkedések hatása az összes kórházi ágyszámra
G Vas, G Imhof, I Ágoston, B Vas, J Betlehem, G Kresák, D Endrei, ...
Egészségügyi gazdasági szemle 47 (4), 5-11, 2009
Planning, implementation and operation of a personalized patient management system for subjects with first suspect of cancer (OnkoNetwork): system description based on a …
JG Pitter, M Csanádi, A Szigeti, G Lukács, Á Kovács, M Moizs, I Repa, ...
BMC health services research 19, 1-13, 2019
Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges
R Daubner-Bendes, S Kovács, M Niewada, M Huic, M Drummond, ...
Frontiers in Public Health 8, 612410, 2021
Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening
P Elek, P Fadgyas-Freyler, B Váradi, B Mayer, A Zemplényi, M Csanádi
Health Policy 126 (8), 763-769, 2022
Regulatory and HTA early dialogues in medical devices
CR Blankart, F Dams, H Penton, Z Kaló, A Zemplényi, K Shatrov, ...
Health Policy 125 (10), 1322-1329, 2021
Behind the subcutaneous trastuzumab hype: evaluation of benefits and their transferability to Central Eastern European countries
A Inotai, T Ágh, AW Karpenko, A Zemplényi, Z Kaló
Expert Review of Pharmacoeconomics & Outcomes Research 19 (2), 105-113, 2019
Barriers to use artificial intelligence methodologies in health technology assessment in central and east European countries
K Tachkov, A Zemplenyi, M Kamusheva, M Dimitrova, P Siirtola, J Pontén, ...
Frontiers in Public Health 10, 921226, 2022
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta …
RG Vida, E Sághy, R Bella, S Kovács, D Erdősi, J Józwiak-Hagymásy, ...
BMC psychiatry 23 (1), 545, 2023
Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study
K Ocskay, MF Juhász, N Farkas, N Zádori, L Szakó, Z Szakács, A Szentesi, ...
BMJ open 12 (1), e050821, 2022
Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries
S Kovács, Z Kaló, R Daubner‐Bendes, K Kolasa, R Hren, T Tesar, ...
Health Economics 31, 195-206, 2022
Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers
M Kamusheva, B Németh, A Zemplényi, Z Kaló, J Elvidge, M Dimitrova, ...
Journal of Comparative Effectiveness Research 11 (12), 905-913, 2022
Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder
A Zemplényi, J Józwiak-Hagymásy, S Kovács, D Erdősi, I Boncz, T Tényi, ...
BMC psychiatry 22 (1), 437, 2022
The system can't perform the operation now. Try again later.
Articles 1–20